title: Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
abstract: Gastric cancer remains difficult to cure and has a poor overall prognosis. Chemotherapy and multimodality therapy has shown some benefit in the treatment of gastric cancer. Current therapies for gastric cancer have their limitations; thus, we are in need of newer treatment options including targeted therapies. Here, we review the biologic therapy with trastuzumab in human epidermal growth factor receptor 2 (HER2)+ gastric cancer.
authors: Division of Hematology/Oncology, Tufts Medical Center, Boston, MA, USA.
authors: Krishna S
authors: KS
authors: Gunturu
authors: Yanghee
authors: Y
authors: Woo
authors: Nike
authors: N
authors: Beaubier
authors: Helen E
authors: HE
authors: Remotti
authors: M Wasif
authors: MW
authors: Saif
keywords: gastric cancer; trastuzumab